Risk stratification for wilms tumor: current approach and future directions

scientific article

Risk stratification for wilms tumor: current approach and future directions is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.14694/EDBOOK_AM.2014.34.215
P698PubMed publication ID24857079

P50authorNorbert GrafQ39739734
Jeffrey S DomeQ90449457
P2093author name stringElizabeth J. Perlman
P407language of work or nameEnglishQ1860
P921main subjectnephroblastomaQ756289
P304page(s)215-23
P577publication date2014-01-01
P1433published inAmerican Society of Clinical Oncology educational book / ASCOQ26842316
P1476titleRisk stratification for wilms tumor: current approach and future directions

Reverse relations

cites work (P2860)
Q28083988Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration
Q38843141Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group
Q92866879Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report
Q61847867Botryoid Wilms tumor: a non-existent “entity” causing diagnostic and staging difficulties
Q51739895Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.
Q90643339Development and validation of a nomogram for predicting cancer-specific survival in patients with Wilms' tumor
Q58785977Educational Case: Wilms Tumor
Q55402955Evaluation of renal tumors in children.
Q38734260Factors possibly affecting prognosis in children with Wilms' tumor diagnosed before 24 months of age: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Wilms Tumor Working Group.
Q36052678Genetic and chromosomal alterations in Kenyan Wilms Tumor
Q37146691Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic review
Q55262812Germline mutations and somatic inactivation of TRIM28 in Wilms tumour.
Q91729017Less may be more for stage I epithelial Wilms tumors
Q90041553Loss of Heterozygosity at Chromosome 16q Is a Negative Prognostic Factor in Korean Pediatric Patients with Favorable Histology Wilms Tumor: A Report of the Korean Pediatric Hematology Oncology Group (K-PHOG)
Q42371655Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms' tumor: a meta-analysis.
Q59137136Lymph node imaging of pediatric renal and suprarenal malignancies
Q37706888Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
Q47797328Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
Q30381395Peptide spectra in Wilms tumor that associate with adverse outcomes
Q92219613Prognostic Factors and Nomograms to Predict Overall and Cancer-Specific Survival for Children with Wilms' Tumor
Q50693805Prospective analysis of long-term renal function in survivors of childhood Wilms tumor.
Q89365159Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database
Q38630842Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group
Q95852637Results of treatment for patients with multicentric or bilaterally predisposed unilateral Wilms tumor (AREN0534): A report from the Children's Oncology Group
Q38972223Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group.
Q48570161Surgical concepts in the treatment of Wilms tumor: An update
Q47141863TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia
Q38815578The Evolving Role of Minimally Invasive Surgery in Pediatric and Adolescent Urologic Oncology
Q42995400The IGF signalling pathway in Wilms tumours--a report from the ENCCA Renal Tumours Biology-driven drug development workshop
Q57476574The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol
Q91297749The genetic changes of Wilms tumour
Q33552390The prognostic significance of hypertension at diagnosis in children with wilms tumor
Q53657080Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG).
Q35622321Tumor size and prognosis in patients with Wilms tumor
Q49846900Two rare cases of abdominal tumor in children: Answers
Q54336619Whole-tumor apparent diffusion coefficient measurements in nephroblastoma: Can it identify blastemal predominance?
Q47137911Wilms Tumor Treatment Outcomes: Perspectives From a Low-Income Setting

Search more.